-
1
-
-
78751588734
-
Failure to metformin and insulin secretagogue monotherapy: an observational cohort study
-
Pala L, Monami M, Lamanna C, Cresci B, Colombi C, Bardini G, et al. Failure to metformin and insulin secretagogue monotherapy: an observational cohort study. Acta Diabetol. 2010;47 Suppl 1:7-11.
-
(2010)
Acta Diabetol
, vol.47
, Issue.SUPPL. 1
, pp. 7-11
-
-
Pala, L.1
Monami, M.2
Lamanna, C.3
Cresci, B.4
Colombi, C.5
Bardini, G.6
-
2
-
-
0032983666
-
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49).UK Prospective Diabetes Study (UKPDS) Group.
-
Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA. 1999;281(21):2005-12.
-
(1999)
JAMA
, vol.281
, Issue.21
, pp. 2005-2012
-
-
Turner, R.C.1
Cull, C.A.2
Frighi, V.3
Holman, R.R.4
-
3
-
-
0032511583
-
UK Prospective Diabetes Study (UKPDS) Group
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837-53.
-
(1998)
Lancet.
, vol.352
, Issue.9131
, pp. 837-853
-
-
-
4
-
-
0034641568
-
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
-
Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405-12.
-
(2000)
BMJ.
, vol.321
, Issue.7258
, pp. 405-412
-
-
Stratton, I.M.1
Adler, A.I.2
Neil, H.A.3
Matthews, D.R.4
Manley, S.E.5
Cull, C.A.6
-
5
-
-
43849105857
-
Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial
-
Weng J, Li Y, Xu W, Shi L, Zhang Q, Zhu D, et al. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet. 2008;371(9626):1753-60.
-
(2008)
Lancet.
, vol.371
, Issue.9626
, pp. 1753-1760
-
-
Weng, J.1
Li, Y.2
Xu, W.3
Shi, L.4
Zhang, Q.5
Zhu, D.6
-
6
-
-
15944395997
-
Insulin therapy in type 2 diabetes
-
New York: Medical Information Pr.
-
Rosenstock Julio, Riddle Matthew C. Insulin therapy in type 2 diabetes. The CADRE Handbook of Diabetes Management. New York: Medical Information Pr. 2004:145-68.
-
(2004)
The CADRE Handbook of Diabetes Management.
, pp. 145-168
-
-
Julio, R.1
Matthew, C.R.2
-
7
-
-
0030915548
-
Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulinanalog treatment
-
Anderson JH, Jr, Brunelle RL, Koivisto VA, Pfutzner A, Trautmann ME, Vignati L, et al. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulinanalog treatment. Multicenter Insulin Lispro Study Group. Diabetes. 1997;46(2):265-70.
-
(1997)
Multicenter Insulin Lispro Study Group. Diabetes.
, vol.46
, Issue.2
, pp. 265-270
-
-
Anderson, J.H.1
Brunelle, R.L.2
Koivisto, V.A.3
Pfutzner, A.4
Trautmann, M.E.5
Vignati, L.6
-
9
-
-
34548329984
-
A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients
-
Pala L, Mannucci E, Dicembrini I, Rotella CM. A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients. Diabetes Res Clin Pract. 2007;78(1):132-5.
-
(2007)
Diabetes Res Clin Pract.
, vol.78
, Issue.1
, pp. 132-135
-
-
Pala, L.1
Mannucci, E.2
Dicembrini, I.3
Rotella, C.M.4
-
10
-
-
0030991976
-
Health-related quality-of-life results from multinational clinical trials of insulin lispro
-
Kotsanos JG, Vignati L, Huster W, Andrejasich C, Boggs MB, Jacobson AM, et al. Health-related quality-of-life results from multinational clinical trials of insulin lispro. Assessing benefits of a new diabetes therapy. Diabetes Care. 1997;20(6):948-58.
-
(1997)
Assessing benefits of a new diabetes therapy. Diabetes Care.
, vol.20
, Issue.6
, pp. 948-958
-
-
Kotsanos, J.G.1
Vignati, L.2
Huster, W.3
Andrejasich, C.4
Boggs, M.B.5
Jacobson, A.M.6
-
12
-
-
47649100195
-
Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a metaanalysis
-
Monami M, Marchionni N, Mannucci E. Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a metaanalysis. Diabetes Res Clin Pract. 2008;81(2):184-9.
-
(2008)
Diabetes Res Clin Pract.
, vol.81
, Issue.2
, pp. 184-189
-
-
Monami, M.1
Marchionni, N.2
Mannucci, E.3
-
13
-
-
70350605350
-
Comparison of insulin detemir and insulin glargine using a basal-bolus regimen in a randomized, controlled clinical study in patients with type 2 diabetes
-
Raskin P, Gylvin T, Weng W, Chaykin L. Comparison of insulin detemir and insulin glargine using a basal-bolus regimen in a randomized, controlled clinical study in patients with type 2 diabetes. Diabetes Metab Res Rev. 2009;25(6):542-8.
-
(2009)
Diabetes Metab Res Rev.
, vol.25
, Issue.6
, pp. 542-548
-
-
Raskin, P.1
Gylvin, T.2
Weng, W.3
Chaykin, L.4
-
14
-
-
84866268783
-
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
-
Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35(6):1364-79.
-
(2012)
Diabetes Care.
, vol.35
, Issue.6
, pp. 1364-1379
-
-
Inzucchi, S.E.1
Bergenstal, R.M.2
Buse, J.B.3
Diamant, M.4
Ferrannini, E.5
Nauck, M.6
-
15
-
-
60449089649
-
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
-
Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32(1):193-203.
-
(2009)
Diabetes Care.
, vol.32
, Issue.1
, pp. 193-203
-
-
Nathan, D.M.1
Buse, J.B.2
Davidson, M.B.3
Ferrannini, E.4
Holman, R.R.5
Sherwin, R.6
-
16
-
-
35548947584
-
Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes
-
Holman RR, Thorne KI, Farmer AJ, Davies MJ, Keenan JF, Paul S, et al. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. N Engl J Med. 2007;357(17):1716-30.
-
(2007)
N Engl J Med.
, vol.357
, Issue.17
, pp. 1716-1730
-
-
Holman, R.R.1
Thorne, K.I.2
Farmer, A.J.3
Davies, M.J.4
Keenan, J.F.5
Paul, S.6
-
17
-
-
84857640868
-
The insulin and insulin-like growth factor receptor family in neoplasia: an update
-
Pollak M. The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat Rev Cancer. 2012;12(3):159-69.
-
(2012)
Nat Rev Cancer.
, vol.12
, Issue.3
, pp. 159-169
-
-
Pollak, M.1
-
18
-
-
70849120946
-
Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease
-
Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri R. Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev. 2009;30(6):586-623.
-
(2009)
Endocr Rev.
, vol.30
, Issue.6
, pp. 586-623
-
-
Belfiore, A.1
Frasca, F.2
Pandini, G.3
Sciacca, L.4
Vigneri, R.5
-
19
-
-
77955515434
-
Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling
-
Sciacca L, Cassarino MF, Genua M, Pandini G, Le Moli R, Squatrito S, et al. Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling. Diabetologia. 2010;53(8):1743-53.
-
(2010)
Diabetologia.
, vol.53
, Issue.8
, pp. 1743-1753
-
-
Sciacca, L.1
Cassarino, M.F.2
Genua, M.3
Pandini, G.4
Le Moli, R.5
Squatrito, S.6
-
20
-
-
84863189303
-
Systematic review and meta-analysis of insulin therapy and risk of cancer
-
Janghorbani M, Dehghani M, Salehi-Marzijarani M. Systematic review and meta-analysis of insulin therapy and risk of cancer. Horm Cancer. 2012;3(4):137-46.
-
(2012)
Horm Cancer.
, vol.3
, Issue.4
, pp. 137-146
-
-
Janghorbani, M.1
Dehghani, M.2
Salehi-Marzijarani, M.3
-
21
-
-
77953537179
-
Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure
-
Bowker SL, Yasui Y, Veugelers P, Johnson JA. Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure. Diabetologia. 2010;53(8):1631-7.
-
(2010)
Diabetologia.
, vol.53
, Issue.8
, pp. 1631-1637
-
-
Bowker, S.L.1
Yasui, Y.2
Veugelers, P.3
Johnson, J.A.4
-
22
-
-
84864270406
-
Basal insulin and cardiovascular and other outcomes in dysglycemia
-
Gerstein HC, Bosch J, Dagenais GR, Diaz R, Jung H, Maggioni AP, et al. Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med. 2012;367(4):319-28.
-
(2012)
N Engl J Med.
, vol.367
, Issue.4
, pp. 319-328
-
-
Gerstein, H.C.1
Bosch, J.2
Dagenais, G.R.3
Diaz, R.4
Jung, H.5
Maggioni, A.P.6
-
23
-
-
79957588372
-
Comparison of intracellular signalling by insulin and the hypermitogenic AspB10 analogue in MCF-7 breast adenocarcinoma cells
-
Oleksiewicz MB, Bonnesen C, Hegelund AC, Lundby A, Holm GM, Jensen MB, et al. Comparison of intracellular signalling by insulin and the hypermitogenic AspB10 analogue in MCF-7 breast adenocarcinoma cells. J Appl Toxicol. 2011;31(4):329-41.
-
(2011)
J Appl Toxicol.
, vol.31
, Issue.4
, pp. 329-341
-
-
Oleksiewicz, M.B.1
Bonnesen, C.2
Hegelund, A.C.3
Lundby, A.4
Holm, G.M.5
Jensen, M.B.6
-
24
-
-
0342657181
-
Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use
-
Kurtzhals P, Schaffer L, Sorensen A, Kristensen C, Jonassen I, Schmid C, et al. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes. 2000;49(6):999-1005.
-
(2000)
Diabetes.
, vol.49
, Issue.6
, pp. 999-1005
-
-
Kurtzhals, P.1
Schaffer, L.2
Sorensen, A.3
Kristensen, C.4
Jonassen, I.5
Schmid, C.6
-
25
-
-
68449094354
-
Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group
-
Colhoun HM. Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia. 2009;52(9):1755-65.
-
(2009)
Diabetologia.
, vol.52
, Issue.9
, pp. 1755-1765
-
-
Colhoun, H.M.1
-
26
-
-
68449104156
-
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
-
Hemkens LG, Grouven U, Bender R, Gunster C, Gutschmidt S, Selke GW, et al. Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia. 2009;52(9):1732-44.
-
(2009)
Diabetologia.
, vol.52
, Issue.9
, pp. 1732-1744
-
-
Hemkens, L.G.1
Grouven, U.2
Bender, R.3
Gunster, C.4
Gutschmidt, S.5
Selke, G.W.6
-
27
-
-
68449094325
-
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
-
Currie CJ, Poole CD, Gale EA. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia. 2009;52(9):1766-77.
-
(2009)
Diabetologia.
, vol.52
, Issue.9
, pp. 1766-1777
-
-
Currie, C.J.1
Poole, C.D.2
Gale, E.A.3
-
28
-
-
84856701110
-
Further exploration of the relationship between insulin glargine and incident cancer: a retrospective cohort study of older Medicare patients
-
Morden NE, Liu SK, Smith J, Mackenzie TA, Skinner J, Korc M. Further exploration of the relationship between insulin glargine and incident cancer: a retrospective cohort study of older Medicare patients. Diabetes Care. 2011;34(9):1965-71.
-
(2011)
Diabetes Care.
, vol.34
, Issue.9
, pp. 1965-1971
-
-
Morden, N.E.1
Liu, S.K.2
Smith, J.3
Mackenzie, T.A.4
Skinner, J.5
Korc, M.6
-
29
-
-
84856715759
-
Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study
-
Ruiter R, Visser LE, van Herk-Sukel MP, Coebergh JW, Haak HR, Geelhoed-Duijvestijn PH, et al. Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study. Diabetologia. 2012;55(1):51-62.
-
(2012)
Diabetologia.
, vol.55
, Issue.1
, pp. 51-62
-
-
Ruiter, R.1
Visser, L.E.2
van Herk-Sukel, M.P.3
Coebergh, J.W.4
Haak, H.R.5
Geelhoed-Duijvestijn, P.H.6
-
30
-
-
84858070444
-
The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: an observational study of the time-dependent effects of antidiabetic treatments in patients with diabetes
-
Lind M, Fahlen M, Eliasson B, Oden A. The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: an observational study of the time-dependent effects of antidiabetic treatments in patients with diabetes. Prim Care Diabetes. 2012;6(1):53-9.
-
(2012)
Prim Care Diabetes.
, vol.6
, Issue.1
, pp. 53-59
-
-
Lind, M.1
Fahlen, M.2
Eliasson, B.3
Oden, A.4
-
31
-
-
77954832956
-
Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients
-
Mannucci E, Monami M, Balzi D, Cresci B, Pala L, Melani C, et al. Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients. Diabetes Care. 2010;33(9):1997-2003.
-
(2010)
Diabetes Care.
, vol.33
, Issue.9
, pp. 1997-2003
-
-
Mannucci, E.1
Monami, M.2
Balzi, D.3
Cresci, B.4
Pala, L.5
Melani, C.6
-
32
-
-
80054700909
-
Longterm effects of insulin glargine on the risk of breast cancer
-
Suissa S, Azoulay L, Dell'Aniello S, Evans M, Vora J, Pollak M. Longterm effects of insulin glargine on the risk of breast cancer. Diabetologia. 2011;54(9):2254-62.
-
(2011)
Diabetologia.
, vol.54
, Issue.9
, pp. 2254-2262
-
-
Suissa, S.1
Azoulay, L.2
Dell'Aniello, S.3
Evans, M.4
Vora, J.5
Pollak, M.6
-
34
-
-
45149131667
-
Effects of intensive glucose lowering in type 2 diabetes
-
Gerstein HC, Miller ME, Byington RP, Goff DC, Jr, Bigger JT, Buse JB, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545-59.
-
(2008)
N Engl J Med.
, vol.358
, Issue.24
, pp. 2545-2559
-
-
Gerstein, H.C.1
Miller, M.E.2
Byington, R.P.3
Goff, D.C.4
Bigger, J.T.5
Buse, J.B.6
-
35
-
-
83655161341
-
The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern
-
Currie CJ, Johnson JA. The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern. Diabetes Obes Metab. 2012;14(1):1-4.
-
(2012)
Diabetes Obes Metab.
, vol.14
, Issue.1
, pp. 1-4
-
-
Currie, C.J.1
Johnson, J.A.2
-
36
-
-
0030974812
-
Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group
-
Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ. 1997;314(7093):1512-5.
-
(1997)
BMJ
, vol.314
, Issue.7093
, pp. 1512-1515
-
-
Malmberg, K.1
-
37
-
-
80052522584
-
Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study
-
Mellbin LG, Malmberg K, Norhammar A, Wedel H, Ryden L. Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study. Diabetologia. 2011;54(6):1308-17.
-
(2011)
Diabetologia.
, vol.54
, Issue.6
, pp. 1308-1317
-
-
Mellbin, L.G.1
Malmberg, K.2
Norhammar, A.3
Wedel, H.4
Ryden, L.5
-
38
-
-
73949143669
-
The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction
-
Chaitman BR, Hardison RM, Adler D, Gebhart S, Grogan M, Ocampo S, et al. The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction. Circulation. 2009;120(25):2529-40.
-
(2009)
Circulation.
, vol.120
, Issue.25
, pp. 2529-2540
-
-
Chaitman, B.R.1
Hardison, R.M.2
Adler, D.3
Gebhart, S.4
Grogan, M.5
Ocampo, S.6
-
39
-
-
67650475389
-
Effect of glucose-insulin-potassium infusion on mortality in critical care settings: a systematic review and meta-analysis
-
Puskarich MA, Runyon MS, Trzeciak S, Kline JA, Jones AE. Effect of glucose-insulin-potassium infusion on mortality in critical care settings: a systematic review and meta-analysis. J Clin Pharmacol. 2009;49(7):758-67.
-
(2009)
J Clin Pharmacol.
, vol.49
, Issue.7
, pp. 758-767
-
-
Puskarich, M.A.1
Runyon, M.S.2
Trzeciak, S.3
Kline, J.A.4
Jones, A.E.5
-
40
-
-
0037034257
-
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
-
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
-
(2002)
N Engl J Med.
, vol.346
, Issue.6
, pp. 393-403
-
-
Knowler, W.C.1
Barrett-Connor, E.2
Fowler, S.E.3
Hamman, R.F.4
Lachin, J.M.5
Walker, E.A.6
-
41
-
-
0037097039
-
Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial
-
Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial. Lancet. 2002;359(9323):2072-7.
-
(2002)
Lancet.
, vol.359
, Issue.9323
, pp. 2072-2077
-
-
Chiasson, J.L.1
Josse, R.G.2
Gomis, R.3
Hanefeld, M.4
Karasik, A.5
Laakso, M.6
-
42
-
-
33748748206
-
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial
-
Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet. 2006;368(9541):1096-105.
-
(2006)
Lancet.
, vol.368
, Issue.9541
, pp. 1096-1105
-
-
Gerstein, H.C.1
Yusuf, S.2
Bosch, J.3
Pogue, J.4
Sheridan, P.5
Dinccag, N.6
-
43
-
-
0035799806
-
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance
-
Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343-50.
-
(2001)
N Engl J Med.
, vol.344
, Issue.18
, pp. 1343-1350
-
-
Tuomilehto, J.1
Lindstrom, J.2
Eriksson, J.G.3
Valle, T.T.4
Hamalainen, H.5
Ilanne-Parikka, P.6
-
44
-
-
0038455703
-
Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial
-
Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA. 2003;290(4):486-94.
-
(2003)
JAMA.
, vol.290
, Issue.4
, pp. 486-494
-
-
Chiasson, J.L.1
Josse, R.G.2
Gomis, R.3
Hanefeld, M.4
Karasik, A.5
Laakso, M.6
-
45
-
-
26244453309
-
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
-
Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi- Benedetti M, Moules IK, et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet. 2005;366(9493):1279-89.
-
(2005)
Lancet.
, vol.366
, Issue.9493
, pp. 1279-1289
-
-
Dormandy, J.A.1
Charbonnel, B.2
Eckland, D.J.3
Erdmann, E.4
Massi-Benedetti, M.5
Moules, I.K.6
-
46
-
-
84861131970
-
Incretin-based therapies and cardiovascular risk
-
Mannucci E, Dicembrini I. Incretin-based therapies and cardiovascular risk. Curr Med Res Opin. 2012;28(5):715-21.
-
(2012)
Curr Med Res Opin.
, vol.28
, Issue.5
, pp. 715-721
-
-
Mannucci, E.1
Dicembrini, I.2
-
47
-
-
81855194761
-
Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials
-
Monami M, Dicembrini I, Martelli D, Mannucci E. Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials. Curr Med Res Opin. 2011;27 Suppl 3:57-64.
-
(2011)
Curr Med Res Opin.
, vol.27
, Issue.SUPPL. 3
, pp. 57-64
-
-
Monami, M.1
Dicembrini, I.2
Martelli, D.3
Mannucci, E.4
-
48
-
-
68349130799
-
Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials
-
Mannucci E, Monami M, Lamanna C, Gori F, Marchionni N. Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis. 2009;19(9):604-12.
-
(2009)
Nutr Metab Cardiovasc Dis.
, vol.19
, Issue.9
, pp. 604-612
-
-
Mannucci, E.1
Monami, M.2
Lamanna, C.3
Gori, F.4
Marchionni, N.5
-
49
-
-
79951708837
-
Metformin and cancer occurrence in insulin-treated type 2 diabetic patients
-
Monami M, Colombi C, Balzi D, Dicembrini I, Giannini S, Melani C, et al. Metformin and cancer occurrence in insulin-treated type 2 diabetic patients. Diabetes Care. 2011;34(1):129-31.
-
(2011)
Diabetes Care.
, vol.34
, Issue.1
, pp. 129-131
-
-
Monami, M.1
Colombi, C.2
Balzi, D.3
Dicembrini, I.4
Giannini, S.5
Melani, C.6
-
50
-
-
84893479171
-
Combination Therapies of DPP4 Inhibitors and GLP1 Analogues with Insulin in Type 2 Diabetic Patients: A Systematic Review Curr Vasc Pharmacol
-
Rizos EC, Ntzani EE, Papanas N, Tsimihodimos V, Mitrogianni Z, Maltezos E, et al. Combination Therapies of DPP4 Inhibitors and GLP1 Analogues with Insulin in Type 2 Diabetic Patients: A Systematic Review. Curr Vasc Pharmacol. 2012.
-
(2012)
-
-
Rizos, E.C.1
Ntzani, E.E.2
Papanas, N.3
Tsimihodimos, V.4
Mitrogianni, Z.5
Maltezos, E.6
-
51
-
-
79960758089
-
An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemia
-
Fonseca V, Gill J, Zhou R, Leahy J. An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemia. Diabetes Obes Metab. 2011;13(9):814-22.
-
(2011)
Diabetes Obes Metab.
, vol.13
, Issue.9
, pp. 814-822
-
-
Fonseca, V.1
Gill, J.2
Zhou, R.3
Leahy, J.4
-
52
-
-
77954356742
-
Cardiac safety profile of rosiglitazone: a comprehensive meta-analysis of randomized clinical trials
-
Mannucci E, Monami M, Di Bari M, Lamanna C, Gori F, Gensini GF, et al. Cardiac safety profile of rosiglitazone: a comprehensive meta-analysis of randomized clinical trials. Int J Cardiol. 2010;143(2):135-40.
-
(2010)
Int J Cardiol.
, vol.143
, Issue.2
, pp. 135-140
-
-
Mannucci, E.1
Monami, M.2
Di Bari, M.3
Lamanna, C.4
Gori, F.5
Gensini, G.F.6
-
53
-
-
84864460325
-
Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin
-
Jonassen I, Havelund S, Hoeg-Jensen T, Steensgaard DB, Wahlund PO, Ribel U. Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin. Pharm Res. 2012;29(8):2104-14.
-
(2012)
Pharm Res.
, vol.29
, Issue.8
, pp. 2104-2114
-
-
Jonassen, I.1
Havelund, S.2
Hoeg-Jensen, T.3
Steensgaard, D.B.4
Wahlund, P.O.5
Ribel, U.6
-
54
-
-
82955198015
-
Insulin degludec: a new ultra-long, basal insulin designed to maintain full metabolic effect while minimizing mitogenic potential
-
Nishimura E, Sorensen AR, Hansen BF, Stidsen CE, Olsen GS, Schaffer L, et al. Insulin degludec: a new ultra-long, basal insulin designed to maintain full metabolic effect while minimizing mitogenic potential. Diabetologia. 2010;53(Suppl 1):S388.
-
(2010)
Diabetologia.
, vol.53
, Issue.SUPPL. 1
-
-
Nishimura, E.1
Sorensen, A.R.2
Hansen, B.F.3
Stidsen, C.E.4
Olsen, G.S.5
Schaffer, L.6
-
55
-
-
84859921058
-
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
-
Garber AJ, King AB, Del Prato S, Sreenan S, Balci MK, Munoz-Torres M, et al. Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial. Lancet. 2012;379(9825):1498-507.
-
(2012)
Lancet.
, vol.379
, Issue.9825
, pp. 1498-1507
-
-
Garber, A.J.1
King, A.B.2
Del Prato, S.3
Sreenan, S.4
Balci, M.K.5
Munoz-Torres, M.6
-
56
-
-
84884246875
-
Contrasting Weight Changes with LY2605541, a Novel Long-Acting Insulin, and Insulin Glargine Despite Similar Improved Glycemic Control in T1D and T2D
-
Philadelphia, PA.
-
Contrasting Weight Changes with LY2605541, a Novel Long-Acting Insulin, and Insulin Glargine Despite Similar Improved Glycemic Control in T1D and T2D. Philadelphia, PA. 2012.
-
(2012)
-
-
-
57
-
-
49249136821
-
A novel insulin formulation with a more rapid onset of action
-
Steiner S, Hompesch M, Pohl R, Simms P, Flacke F, Mohr T, et al. A novel insulin formulation with a more rapid onset of action. Diabetologia. 2008;51(9):1602-6.
-
(2008)
Diabetologia.
, vol.51
, Issue.9
, pp. 1602-1606
-
-
Steiner, S.1
Hompesch, M.2
Pohl, R.3
Simms, P.4
Flacke, F.5
Mohr, T.6
-
58
-
-
67649849974
-
Accelerated pharmacokinetics and glucodynamics of prandial insulins injected with recombinant human hyaluronidase
-
Vaughn DE, Yocum RC, Muchmore DB, Sugarman BJ, Vick AM, Bilinsky IP, et al. Accelerated pharmacokinetics and glucodynamics of prandial insulins injected with recombinant human hyaluronidase. Diabetes Technol Ther. 2009;11(6):345-52.
-
(2009)
Diabetes Technol Ther.
, vol.11
, Issue.6
, pp. 345-352
-
-
Vaughn, D.E.1
Yocum, R.C.2
Muchmore, D.B.3
Sugarman, B.J.4
Vick, A.M.5
Bilinsky, I.P.6
-
59
-
-
77956159186
-
Practical aspects and considerations when switching between continuous subcutaneous insulin infusion and multiple daily injections
-
Meneghini L, Sparrow-Bodenmiller J. Practical aspects and considerations when switching between continuous subcutaneous insulin infusion and multiple daily injections. Diabetes Technol Ther. 2010;12 Suppl 1:S109-14.
-
(2010)
Diabetes Technol Ther.
, vol.12
, Issue.SUPPL. 1
-
-
Meneghini, L.1
Sparrow-Bodenmiller, J.2
-
60
-
-
41149150167
-
Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes
-
Pickup JC, Renard E. Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes. Diabetes Care. 2008;31 Suppl 2:S140-5.
-
(2008)
Diabetes Care.
, vol.31
, Issue.SUPPL. 2
-
-
Pickup, J.C.1
Renard, E.2
-
61
-
-
77956158414
-
Continuous subcutaneous insulin infusion--an historical perspective
-
Skyler JS. Continuous subcutaneous insulin infusion--an historical perspective. Diabetes Technol Ther. 2010;12 Suppl 1:S5-9.
-
(2010)
Diabetes Technol Ther.
, vol.12
, Issue.SUPPL. 1
-
-
Skyler, J.S.1
-
62
-
-
67651222767
-
Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysis
-
Monami M, Lamanna C, Marchionni N, Mannucci E. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysis. Exp Clin Endocrinol Diabetes. 2009;117(5):220-2.
-
(2009)
Exp Clin Endocrinol Diabetes.
, vol.117
, Issue.5
, pp. 220-222
-
-
Monami, M.1
Lamanna, C.2
Marchionni, N.3
Mannucci, E.4
-
63
-
-
77956143443
-
Insulin patch pumps: their development and future in closed-loop systems
-
Anhalt H, Bohannon NJ. Insulin patch pumps: their development and future in closed-loop systems. Diabetes Technol Ther. 2010;12 Suppl 1:S51-8.
-
(2010)
Diabetes Technol Ther.
, vol.12
, Issue.SUPPL. 1
-
-
Anhalt, H.1
Bohannon, N.J.2
-
64
-
-
33645051466
-
Continuous glucose monitoring and closed-loop systems
-
Hovorka R. Continuous glucose monitoring and closed-loop systems. Diabet Med. 2006;23(1):1-12.
-
(2006)
Diabet Med.
, vol.23
, Issue.1
, pp. 1-12
-
-
Hovorka, R.1
-
65
-
-
74249093844
-
Closedloop insulin delivery using a subcutaneous glucose sensor and intraperitoneal insulin delivery: feasibility study testing a new model for the artificial pancreas
-
Renard E, Place J, Cantwell M, Chevassus H, Palerm CC. Closedloop insulin delivery using a subcutaneous glucose sensor and intraperitoneal insulin delivery: feasibility study testing a new model for the artificial pancreas. Diabetes Care. 2010;33(1):121-7.
-
(2010)
Diabetes Care.
, vol.33
, Issue.1
, pp. 121-127
-
-
Renard, E.1
Place, J.2
Cantwell, M.3
Chevassus, H.4
Palerm, C.C.5
-
66
-
-
80053533327
-
Inhaled insulin: too soon to be forgotten?
-
Zarogoulidis P, Papanas N, Kouliatsis G, Spyratos D, Zarogoulidis K, Maltezos E. Inhaled insulin: too soon to be forgotten? J Aerosol Med Pulm Drug Deliv. 2011;24(5):213-23.
-
(2011)
J Aerosol Med Pulm Drug Deliv
, vol.24
, Issue.5
, pp. 213-223
-
-
Zarogoulidis, P.1
Papanas, N.2
Kouliatsis, G.3
Spyratos, D.4
Zarogoulidis, K.5
Maltezos, E.6
-
67
-
-
84861305773
-
Buccal spray insulin (Oralgen) for type 2 diabetes: what evidence
-
Palermo A, Maddaloni E, Pozzilli P. Buccal spray insulin (Oralgen) for type 2 diabetes: what evidence? Expert Opin Biol Ther. 2012;12(6):767-72.
-
(2012)
Expert Opin Biol Ther
, vol.12
, Issue.6
, pp. 767-772
-
-
Palermo, A.1
Maddaloni, E.2
Pozzilli, P.3
-
68
-
-
19944400122
-
Dose-response relationship of oral insulin spray in healthy subjects
-
Cernea S, Kidron M, Wohlgelernter J, Modi P, Raz I. Dose-response relationship of oral insulin spray in healthy subjects. Diabetes Care. 2005;28(6):1353-7.
-
(2005)
Diabetes Care.
, vol.28
, Issue.6
, pp. 1353-1357
-
-
Cernea, S.1
Kidron, M.2
Wohlgelernter, J.3
Modi, P.4
Raz, I.5
-
69
-
-
1242276363
-
Beneficial effects of addition of oral spray insulin (Oralin) on insulin secretion and metabolic control in subjects with type 2 diabetes mellitus suboptimally controlled on oral hypoglycemic agents
-
Guevara-Aguirre J, Guevara M, Saavedra J, Mihic M, Modi P. Beneficial effects of addition of oral spray insulin (Oralin) on insulin secretion and metabolic control in subjects with type 2 diabetes mellitus suboptimally controlled on oral hypoglycemic agents. Diabetes Technol Ther. 2004;6(1):1-8.
-
(2004)
Diabetes Technol Ther.
, vol.6
, Issue.1
, pp. 1-8
-
-
Guevara-Aguirre, J.1
Guevara, M.2
Saavedra, J.3
Mihic, M.4
Modi, P.5
-
70
-
-
11144254615
-
Oral spray insulin in treatment of type 2 diabetes: a comparison of efficacy of the oral spray insulin (Oralin) with subcutaneous (SC) insulin injection, a proof of concept study
-
Guevara-Aguirre J, Guevara M, Saavedra J, Mihic M, Modi P. Oral spray insulin in treatment of type 2 diabetes: a comparison of efficacy of the oral spray insulin (Oralin) with subcutaneous (SC) insulin injection, a proof of concept study. Diabetes Metab Res Rev. 2004;20(6):472-8.
-
(2004)
Diabetes Metab Res Rev.
, vol.20
, Issue.6
, pp. 472-478
-
-
Guevara-Aguirre, J.1
Guevara, M.2
Saavedra, J.3
Mihic, M.4
Modi, P.5
-
71
-
-
78649704523
-
Buccal spray insulin in subjects with impaired glucose tolerance: the prevoral study
-
Palermo A, Napoli N, Manfrini S, Lauria A, Strollo R, Pozzilli P. Buccal spray insulin in subjects with impaired glucose tolerance: the prevoral study. Diabetes Obes Metab. 2011;13(1):42-6.
-
(2011)
Diabetes Obes Metab.
, vol.13
, Issue.1
, pp. 42-46
-
-
Palermo, A.1
Napoli, N.2
Manfrini, S.3
Lauria, A.4
Strollo, R.5
Pozzilli, P.6
-
72
-
-
84859527968
-
Simultaneous pancreas kidney transplant versus other kidney transplant options in patients with type 2 diabetes
-
Wiseman AC, Gralla J. Simultaneous pancreas kidney transplant versus other kidney transplant options in patients with type 2 diabetes. Clin J Am Soc Nephrol. 2012;7(4):656-64.
-
(2012)
Clin J Am Soc Nephrol.
, vol.7
, Issue.4
, pp. 656-664
-
-
Wiseman, A.C.1
Gralla, J.2
-
73
-
-
84863760366
-
Sustained exendin-4 secretion through gene therapy targeting salivary glands in two different rodent models of obesity/type 2 diabetes
-
Di Pasquale G, Dicembrini I, Raimondi L, Pagano C, Egan JM, Cozzi A, et al. Sustained exendin-4 secretion through gene therapy targeting salivary glands in two different rodent models of obesity/type 2 diabetes. PLoS One. 2012;7(7).
-
(2012)
PLoS One.
, vol.7
, Issue.7
-
-
Di Pasquale, G.1
Dicembrini, I.2
Raimondi, L.3
Pagano, C.4
Egan, J.M.5
Cozzi, A.6
-
74
-
-
79952183409
-
Remission of diabetes by insulin gene therapy using a hepatocyte-specific and glucoseresponsive synthetic promoter
-
Han J, McLane B, Kim EH, Yoon JW, Jun HS. Remission of diabetes by insulin gene therapy using a hepatocyte-specific and glucoseresponsive synthetic promoter. Mol Ther. 2011;19(3):470-8.
-
(2011)
Mol Ther.
, vol.19
, Issue.3
, pp. 470-478
-
-
Han, J.1
McLane, B.2
Kim, E.H.3
Yoon, J.W.4
Jun, H.S.5
|